Partnervest Advisory Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$639K Buy
2,252
+233
+12% +$65K 0.2% 91
2020
Q2
$540K Buy
2,019
+639
+46% +$192K 0.2% 92
2020
Q1
$436K Buy
1,380
+418
+43% +$127K 0.2% 95
2019
Q4
$285K Buy
962
+66
+7% +$18.3K 0.1% 157
2019
Q3
$209K Sell
896
-18
-2% -$4.19K 0.07% 213
2019
Q2
$213K Buy
+914
New +$211K 0.08% 198
2014
Q3
Sell
-3
Closed -$1K 215
2014
Q2
$1K Hold
3
﹤0.01% 996
2014
Q1
$1K Sell
3
-47
-94% -$14.9K ﹤0.01% 982
2013
Q4
$14K Hold
50
0.01% 557
2013
Q3
$12K Hold
50
0.01% 606
2013
Q2
$11K Buy
+50
New +$10.7K 0.01% 575

Other funds holding BIIB

Partnervest Advisory Services's BIIB Position: Q3 2020 in Review

Partnervest Advisory Services increased its Biogen (BIIB) stake by 12% in Q3 2020, buying an estimated $65K and bringing the position to 2,252 shares worth $639K. The position accounts for 0.2% of the portfolio, ranked #91.

Partnervest Advisory Services first reported a position in BIIB in Q2 2013 and has held it in 11 quarters since. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • Partnervest Advisory Services held 2,252 shares of Biogen worth $639K as of Q3 2020.
  • Partnervest Advisory Services bought 233 Biogen shares in Q3 2020, an estimated $65K.
  • Biogen made up 0.2% of Partnervest Advisory Services's portfolio in Q3 2020, its #91 holding.
  • Partnervest Advisory Services first reported a position in Biogen in Q2 2013 and has held it in 11 quarters since.
  • 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Partnervest Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.